As U.S. manufacturers hit their stride, vaccine scarcity will soon turn to plenty as much of the world goes begging. And vaccine makers need answers now about what to do with the coming surplus.
from NYT > Health https://ift.tt/2QFh8iG
via health&fitness
Aucun commentaire:
Enregistrer un commentaire